Alunni-Fabbroni, Marianna http://orcid.org/0000-0002-9710-1662
,
Majunke, Leonie
Trapp, Elisabeth K.
Tzschaschel, Marie
Mahner, Sven
Fasching, Peter A.
Fehm, Tanja
Schneeweiss, Andreas
Beck, Thomas
Lorenz, Ralf
Friedl, Thomas W. P.
Janni, Wolfgang
Rack, Brigitte
Article History
Received: 2 February 2017
Accepted: 22 January 2018
First Online: 6 February 2018
Ethics approval and consent to participate
: The study was approved by all the involved ethical boards (lead ethical board: Ludwig-Maximilians-University Munich) and conducted in accordance with the Declaration of Helsinki. All patients and healthy donors provided written informed consent.
: Not applicable
: In frame of the SUCCESS A clinical trial, BR, WJ, AS, PAF received research funding and/or speaker honoraria from AstraZeneca, Chugai, Lilly, Novartis, Sanofi-Aventis and Janssen Diagnostics. MA-F, TB, RL, TF, TWPF, LM, SM, EKT and MT have no competing interest to declare.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.